Journal of Multiple Sclerosis
ISSN - 2376-0389NLM - 101654564
The effectiveness of fingolimod on clinical and magnetic resonance imaging (MRI) outcomes in patients with multiple sclerosis (MS) has been well established in trials and, to a lesser extent, in the real world
